期刊文献+

p53及其凋亡刺激蛋白对结肠癌细胞自噬和凋亡影响机制探讨 被引量:12

Research of mechanism of p53and apoptosis stimulating protein on autophagy and apoptosis in colon cancer cell
原文传递
导出
摘要 目的探讨p53、p53凋亡刺激蛋白2(apoptosis stimulating protein 2of p53,ASPP2)及异构体ΔASPP2在p53缺陷结肠癌细胞系HCT116-/-细胞中对自噬及凋亡的影响。方法实验分为对照组、MMS组、MMS+p53组、MMS+ASPP2+p53组、MMS+ΔASPP2+p53组和MMS+ASPP2+ΔASPP2+p53组。应用ASPP2、ΔASPP2及p53质粒转染HCT116-/-细胞,同时转染绿色荧光GFP-LC3质粒于各组细胞中,经甲基磺酸(MMS)处理后用荧光显微镜观察细胞自噬水平,蛋白质印迹法检测各组细胞自噬及凋亡相关蛋白表达水平,Calcein AM/PI染色检测细胞凋亡水平。结果自噬水平对照组为(0.63±0.14)%,MMS组为(10.48±0.58)%,MMS+p53组为(5.45±0.41)%,MMS+ASPP2+p53组为(3.43±0.35)%,MMS+ΔASPP2+p53组为(14.84±0.64)%,MMS+ASPP2+ΔASPP2+p53组为(12.29±0.58)%,差异有统计学意义,F=1 182.364,P<0.001;与MMS组比较,MMS+p53组和MMS+ASPP2+p53组自噬水平下降,P值均<0.001;与MMS+p53组相比,MMS+ASPP2+p53组自噬水平降低,P<0.001;MMS+ΔASPP2+p53组自噬水平较MMS+p53处理组增加,P<0.001;MMS+ASPP2+ΔASPP2+p53组自噬水平较MMS+ASPP2+p53组增加,P<0.001。凋亡率比较,对照组为(2.09±0.54)%,MMS组为(16.79±0.69)%,MMS+p53组为(33.70±1.16)%,MMS+ASPP2+p53组为(50.61±1.17)%,MMS+ΔASPP2+p53组为(21.32±1.18)%,MMS+ASPP2+ΔASPP2+p53组为(35.22±1.06)%,差异有统计学意义,F=2 571.942,P<0.001;MMS+p53和MMS+ASPP2+p53组凋亡较MMS组增加,P值均<0.001;与MMS+p53组相比,MMS+ASPP2+p53组凋亡增加,P<0.001;MMS+ΔASPP2+p53组凋亡较MMS+p53组减少,P<0.001;MMS+ASPP2+ΔASPP2+p53组凋亡较MMS+ASPP2+p53组也有所降低,P<0.001。结论 ASPP2能够增强p53的自噬抑制作用,并增强p53促细胞凋亡作用,ΔASPP2能够抑制ASPP2与p53的功能,具有促进细胞自噬,抑制细胞凋亡的作用。 OBJECTIVE To investigate the role of p53,SPP2 and isoform AASPP2 on cell autophagy and apoptosis in non-p53-expressed colon cancer cell line HCTll6-/- cells. METHODS The experiments were divided into 6 groups, including MMS group,MMS+p53 group,MMS+ASPP2+p53 group,MMS+ASPP2+p53 group,MMS+ASPP2+AS- PP2 + p53 group. HCT116 -/ cells were transfected with ASPP2, AASPP2, p53 and GFP-LC3 plasmids, then treated with methanesulfonie acid (MMS). The cell autophagy was observed with immunofluorescence. The expression of autophagy and apoptosis-related protein were detected by using Western blotting. Apoptosis was observed by using Calcein AM/PI. RESULTS The rate of autophagy was (0. 63±0. 14)G in the control group, (10. 48±0. 58)% in the MMS group, (5. 454±0.41)G in the MMS+p53 group,(3.43±0.35)% in the MMS+ASPP2+p53 group, (14.84±0. 64)G in the MMS+AASPP2 +p53 group, and ( 12.29 ± 0. 58)% in the MMS 4- ASPP2 + AASPP2 + p53 group. The difference was statistically significant (F= 1 182. 364, P〈0. 001). Compared with the MMS group, autophagy was decreased in the MMS +p53 group and MMS+ ASPP2+ p53 group (P〈0. 001). Compared with the MMS+ p53 group, autophagy was de- creased in the MMSq-ASPP24-p53 group (P〈0. 001),and autophagy was increased in the AASPP2+p53 group (P〈 0. 001). Compared with the MMS+p53+ASPP2 group,autophagy was increased in the MMS+p53+ASPP2+ AASPP2 group. The rate of apoptosis was (2.09 ± 0.54)% in the control group, (16.79±0.69) % in the MMS group, (33.70 4± 1.16)% in the MMS+p53 group,(50.61±1.17)% in the MMS+ASPP2+p53 group,(21. 324±1.18)% in the MMS+AASPP+p53 group,and (35.22±1.06)% in the MMS+ASPP+△ASPP2+p53 group. The difference was statistically significant (F=2 571. 942 ,P〈0. 001). Compared with the MMS group,apoptosis was increased in the MMS--p53 group and MMS+ASPP2--p53 group (P〈0. 001). Compared with the MMS+p53 group,apoptosis was increased in the MMS 4-ASPP2+p53 group (P〈0. 001) and apoptosis was decreased in the group of AASPP+p53 (P〈0. 001). Compared with the MMS+p53+ASPP2 group,apoptosis was decreased in the group of MMSq-p53+ASPP24-AASPP2. CONCLU- SIONS ASPP2 can enhance the function of p53 that inhibiting cell autophagy and promoting apoptosis,but AASPP2 can inhibit the function of ASPP2 and p53. It has the function of promoting cell autophagy and suppressing cell apoptosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第10期752-757,共6页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81272266)
关键词 P53 p53凋亡刺激蛋白2 ASPP异构体 自噬 细胞凋亡 p53 apoptosis stimulating protein 2 of p53 isoform ASPP2 autophagy apoptosis
  • 相关文献

参考文献15

  • 1Valavanidis A,Vlachogianni T,Fiotakis K, et al. Pulmonary oxi- dative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcino- genesis through reactive oxygen species mechanisms[J]. Int J Environ Res Public Health,2013,10(9) :3886-3907.
  • 2Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: un- derstanding the route to clinical efficacy [J]. Nat Rev Drug Dis- coy, 2014,13(3) : 217-236.
  • 3丁渭,侯庆生,王东阳,刘凯,夏海滨,石英,陈德喜.异构体ΔASPP2可拮抗ASPP2对p53(细胞)凋亡功能的增强作用[J].中国生物化学与分子生物学报,2012,28(2):133-139. 被引量:3
  • 4王贲士,陈德喜,郭洪亮.自噬与肿瘤的研究现状[J].中华肿瘤防治杂志,2014,21(8):637-640. 被引量:8
  • 5Calderwood SK, Khaleque MA, Sawyer DB, et al. Heat shock proteins in eancerchaperones of tumorigenesis[J]. Trends Biochem Sci, 2006, 31(3) : 164-172.
  • 6Wu R,Baker SJ,Hu TC,et al. Type I to type Ⅲ ovarian carci- noma progression: mutant Trp53 or Pik3ca confers a more ag- gressive tumor phenotype in a mouse model of ovarian cancer [J]. Am J Pathol,2013,182(4) :1391-1399.
  • 7Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogen- esis and cancer therapy[J ]. Nat Rev Cancer, 2013,13 ( 2 ) : 83-96.
  • 8Groeger AM, Esposito V, De Luca A, et al. Prognostic value of immu- nohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers[J]. Histopathology, 2004,44 (1) : 54-63.
  • 9Gu J, Tang Y, Liu Y, et al. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/ DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo[J]. Cancer Lett,2014,343(2) :200-209.
  • 10Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family; implications for physiology and therapy[J]. Nat Rev Mol Cell Biol,2014,15(1) :49-63.

二级参考文献22

  • 1YanJIN YongWEI LeiXIONG YingYANG JiaRuiWU.Differential regulation of survivin by p53 contributes to cell cycle dependent apoptosis[J].Cell Research,2005,15(5):361-370. 被引量:21
  • 2Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy [J]. Autophagy,2012,8(4) :445-544.
  • 3JungCH, RoSH, CaoJ, etal. mTORregulationofautophagy [J]. FEBS Lett,2010,584(7): 1287-1295.
  • 4Funderburk SF, Wang QJ, Yue Z. The Beclin 1- VPS34 com-plex-at the crossroads of autophagy and beyond[J]. Trends Cell Biol,2010,20(6) :355-362.
  • 5Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation [J]. Curr Opin Cell Bioi, 2010,22(2): 124-131.
  • 6Levine B, Klionsky DJ. Development by self-digestion: molecu-lar mechanisms and biological functions of autophagy[J]. Dev CeIl,2009,6(4) :463.
  • 7Walsh CM, Edinger AL. The complex interplay between auto-phagy, apoptosis , and necrotic signals promotes T-cell homeo-stasis[J]. Immunol Rev, 2010,236(1) :95-109.
  • 8Mizushima N. Physiological functions of autophagy[M]I I Auto-phagy in infection and immunity. Berlin: Springer Berlin Heidel-berg, 2009: 71-84.
  • 9Djavaheri-Mergny M, Maiuri MC, Kroemer G. Cross talk be-tween apoptosis and autophagy by caspase-mediated cleavage of Beclin l[J]. Oncogene, 2010,29(12):1717-1719.
  • 10Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications[J]. Mol Cancer Thera, 2011, 10(9) :1533-1541.

共引文献9

同被引文献106

  • 1欧阳密霞,胡媛,曾飞.ASPP2,iASPP和p53在宫颈癌组织中的表达及意义[J].中南大学学报(医学版),2015,40(3):256-260. 被引量:8
  • 2刘晓翌,刘建军.Caspase与细胞凋亡[J].武汉大学学报(医学版),2004,25(6):742-745. 被引量:19
  • 3曹信杰,张颖,李会兰,王会平,王志勇,魏莉.重组人p53腺病毒注射液联合化疗治疗恶性体腔积液的疗效观察[J].中国药房,2005,16(23):1809-1810. 被引量:9
  • 4丁维俊,张天娥,王宇,骆永珍.仙鹤草抗癌活性成分及机理探讨[J].辽宁中医杂志,2006,33(2):251-252. 被引量:37
  • 5O'Reilly EA, Gubbins L, Sharma S, et al. The fate of chemore- sistance in triple negative breast cancer (TNBC)[J]. Bba Clini- cal, 2015, 14:257-275.
  • 6Brand TM, Mari I, Dunn EF, et al. Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer[J]. Molecular Cancer Therapeutics, 2014, 13(5) 1356-1368.
  • 7Mueller KL, Madden JM, Zoratti GL, et al. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factorrecep tor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met [J]. Breast Cancer Res, 2012, 14(4):R104.
  • 8Jutten B, Rouschop KM. EGFR signaling and autophagy dependence for growth, survival, and therapy resistance [J]. Cell Cycle, 2014, 13(1) :42-51.
  • 9Hurvitz S, Mead M. Triple-negative breast cancer: advancements in characterization and treatment approach[J]. Curr Opin Obstet Gyne- col, 2016, 28(1): 59-69.
  • 10Mancini P, Angeloni A, Risi E, et al. Standard of care and promis- ing new agents for triple negative metastatic breast cancer[J]. Canc ers, 2014, 6(4):2187 2223.

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部